Τρίτη 2 Φεβρουαρίου 2016

Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment

Abstract

Pseudomyxoma peritonei (PMP) is a neoplastic syndrome characterized by peritoneal tumor implants with copious mucinous ascites. The standard of care for PMP patients is aggressive cytoreductive surgery performed in conjunction with heated intraperitoneal chemotherapy. Not all patients are candidates for these procedures and a majority of the patients will have recurrent disease. In addition to secreted mucin, inflammation and fibrosis are central to PMP pathogenesis but the molecular processes that regulate tumor-stromal interactions within the peritoneal tumor microenvironment remain largely unknown. This knowledge is critical not only to elucidate PMP pathobiology but also to identify novel targets for therapy. Here, we report the generation of patient-derived xenograft (PDX) mouse models for PMP and assess the ability of these models to replicate the inflammatory peritoneal microenvironment of human PMP patients. PDX mouse models of low- and high-grade PMP were generated and were of a similar histopathology as human PMP. Cytokines previously shown to be elevated in human PMP were also elevated in PDX ascites. Significant differences in IL-6 and IL-8/KC/MIP2 were seen between human and PDX ascites. Interestingly, these cytokines were mostly secreted by mouse-derived, tumor-associated stromal cells rather than by human-derived PMP tumor cells. Our data suggest that the PMP PDX mouse models are especially suited to the study of tumor-stromal interactions that regulate the peritoneal inflammatory environment in PMP as the tumor and stromal cells in these mouse models are of human and murine origins, respectively. These mouse models are therefore, likely to be useful in vivo surrogates for testing and developing novel therapeutic treatment interventions for PMP.

Thumbnail image of graphical abstract

Our studies suggest that the human versus mouse species differences that exist in the patient-derived xenograft (PDX) mouse models can be exploited to investigate tumor-stromal interactions that help sustain the inflammatory tumor microenvironment in pseudomyxoma peritonei (PMP). The similarities in chemokine/cytokine profiles between human and PDX PMP suggest that the reciprocal interactions between tumor and tumor-associated stromal components are also likely to be conserved in these PDX models. Therefore, these models are good surrogates for modeling the PMP tumor microenvironment.



from Cancer via ola Kala on Inoreader http://ift.tt/1WZp5HF
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου